These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 16601008

  • 1. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients.
    Choi YS, Ku SY, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH.
    Hum Reprod; 2006 Aug; 21(8):2015-21. PubMed ID: 16601008
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development.
    Wang TH, Chang CL, Wu HM, Chiu YM, Chen CK, Wang HS.
    Fertil Steril; 2006 Nov; 86(5):1392-401. PubMed ID: 17070193
    [Abstract] [Full Text] [Related]

  • 3. Follicular fluid concentrations of IGF-I, IGF-II, IGFBP-3, VEGF, AMH, and inhibin-B in women undergoing controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.
    Kaya A, Atabekoglu CS, Kahraman K, Taskin S, Ozmen B, Berker B, Sonmezer M.
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):167-71. PubMed ID: 22776750
    [Abstract] [Full Text] [Related]

  • 4. [Effect of 7-day gonadotropin-releasing hormone agonist protocol on IGF-II and IGFBP-4 levels in the follicular fluid].
    Zhang J, Li Y, Liu J, Liu De, Liu N, Chen X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 34(3):190-4. PubMed ID: 19349671
    [Abstract] [Full Text] [Related]

  • 5. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY.
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [Abstract] [Full Text] [Related]

  • 6. Concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-3 in the follicular fluid of women undergoing ovarian hyperstimulation with different gonadotropin preparations.
    Nardo LG, Bellanca SA, Burrello N, Longo G, D'Agata R, Nardo F, Calogero AE.
    Gynecol Endocrinol; 2001 Dec; 15(6):413-20. PubMed ID: 11826764
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of ER-alpha polymorphisms and the intrafollicular IGF system for predicting pregnancy in IVF-ET patients.
    Choi YS, Kim SH, Ku SY, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY.
    Gynecol Obstet Invest; 2009 Dec; 67(2):73-80. PubMed ID: 18843190
    [Abstract] [Full Text] [Related]

  • 8. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R, Zohav E, Scharf S, Rabinson J, Meltcer S, Anteby EY, Homburg R.
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy-associated plasma protein-A and insulin-like growth factor binding protein mRNAs in granulosa cells of dominant and subordinate follicles of preovulatory cattle.
    Santiago CA, Voge JL, Aad PY, Allen DT, Stein DR, Malayer JR, Spicer LJ.
    Domest Anim Endocrinol; 2005 Jan; 28(1):46-63. PubMed ID: 15620806
    [Abstract] [Full Text] [Related]

  • 10. Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles.
    Ferrari B, Pezzuto A, Barusi L, Coppola F.
    Gynecol Endocrinol; 2006 Jun; 22(6):289-96. PubMed ID: 16785153
    [Abstract] [Full Text] [Related]

  • 11. Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization.
    Dorn C, Reinsberg J, Kupka M, van der Ven H, Schild RL.
    Arch Gynecol Obstet; 2003 Aug; 268(3):187-93. PubMed ID: 12942249
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S, Chen XN, Qiao J, Liu P, Li R, Chen GA, Ma CH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [Abstract] [Full Text] [Related]

  • 13. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone agonist and antagonists, on follicular fluid stem cell factor and serum urocortin 1 levels on the day of oocyte retrieval.
    Celik O, Celik E, Yilmaz E, Celik N, Turkcuoglu I, Ulas M, Kumbak B, Aktan E, Ozerol I.
    Arch Gynecol Obstet; 2013 Dec; 288(6):1417-22. PubMed ID: 23801011
    [Abstract] [Full Text] [Related]

  • 14. IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol.
    Asimakopoulos B, Schöpper B, Dawson A, Caglar GS, Vakalopoulos I, Al-Hasani S, Diedrich K, Nikolettos N.
    J Endocrinol Invest; 2006 May; 29(5):RC5-8. PubMed ID: 16794358
    [Abstract] [Full Text] [Related]

  • 15. Follicular fluid insulin-like growth factor-I and insulin-like growth factor-binding protein-1 and -3 vary as a function of ovarian reserve and ovarian stimulation.
    Stadtmauer L, Vidali A, Lindheim SR, Sauer MV.
    J Assist Reprod Genet; 1998 Nov; 15(10):587-93. PubMed ID: 9866066
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments.
    Maldonado LG, Franco JG, Setti AS, Iaconelli A, Borges E.
    Fertil Steril; 2013 May; 99(6):1615-22. PubMed ID: 23394779
    [Abstract] [Full Text] [Related]

  • 17. Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin.
    Humaidan P, Westergaard LG, Mikkelsen AL, Fukuda M, Yding Andersen C.
    Fertil Steril; 2011 May; 95(6):2034-8. PubMed ID: 21377153
    [Abstract] [Full Text] [Related]

  • 18. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F, Cobellis L, Mele D, Tassou A, Badolati B, Sorrentino S, De Lucia D, Colacurci N.
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [Abstract] [Full Text] [Related]

  • 19. Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.
    Liu N, Ma Y, Li R, Jin H, Li M, Huang X, Feng HL, Qiao J.
    Endocrine; 2012 Dec; 42(3):708-16. PubMed ID: 22678853
    [Abstract] [Full Text] [Related]

  • 20. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.